Video

Psychiatry Grand Rounds: “Life stories and engagement in underserved populations: Meeting mental health and SUD needs in the community”

Denis Antoine, M.D., FAPA, FASAM, applies the Life Story Perspective to re-think approaches to mental illness and substance use disorder treatments in order to improve individual and societal outcomes.

Video

Psychedelic Treatment with Psilocybin Relieves Major Depression

Roland Griffiths, director of Johns Hopkins Center for Consciousness and Psychedelic Research, describes a milestone study showing that psilocybin relieves major depression.

Video

Psychiatry Grand Rounds: “What is COVID Depression?”

Karen Swartz, M.D. highlights key findings from national surveys.

News

Johns Hopkins Medicine Receives First Federal Grant for Psychedelic Treatment Research in 50 years

Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.

News

Amyloid Beta and Serotonin May Be Keys to Predicting Who Develops Late-Life Depression

Looking for ways to image the human brain for the earliest signs of aging and cognitive decline, Johns Hopkins Medicine researchers recently identified a pattern that links the accumulation of amyloid beta (A?) proteins (associated with ...

News

Gun Shy

Addressing a major risk factor in suicide — particularly among veterans — will require doctors to confront a subject too many feel ill-equipped to discuss.